Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Hepatitis

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...

Viral Hepatitis I: Introduction

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...

Cirrhosis I: Introduction

Cirrhosis I: Introduction

Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...

Cirrhosis II: Pathophysiology

Cirrhosis II: Pathophysiology

Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...

CNS Depressants: Alcohol and Nicotine

CNS Depressants: Alcohol and Nicotine

Ethanol, a clear colorless alcohol, has been consumed by humans for millennia, but its effects on the body are far from benign. At lower doses, it induces decreased inhibitions and loquaciousness, leading to its social appeal. However, it can cause severe consequences at higher doses, such as coma and respiratory depression, due to its zero-order elimination kinetics. Chronic ethanol abuse wreaks havoc on multiple organ systems, particularly the CNS and the liver. Abrupt cessation of ethanol...

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug binding...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Alcoholic liver disease - assessment and management.

Australian family physician·2011

Same author

Characteristics and outcomes of upper gastrointestinal hemorrhage in a tertiary referral hospital.

Digestive diseases and sciences·2010

Same author

The role of general practitioners in managing and treating hepatitis C.

The Medical journal of Australia·2010

Same author

Coeliac disease: to screen or not to screen, that is the question.

The Medical journal of Australia·2009

Same author

Gastrointestinal hemorrhage: should we transfuse less?

Digestive diseases and sciences·2008

Same author

Colorectal cancer screening: ensuring benefits outweigh the risks.

The Medical journal of Australia·2008

Search research articles

Related Experiment Video

Updated: Jul 14, 2026

A Protocol for Analyzing Hepatitis C Virus Replication

A Protocol for Analyzing Hepatitis C Virus Replication

Published on: June 26, 2014

Alcohol and hepatitis C.

John M Duggan¹, Anne E Duggan

¹Princeton Medical Centre, Newcastle, New South Wales, Australia. duggan@hunterlink.net.au

The Medical Journal of Australia

|July 4, 2007

Summary

Hepatitis C can be a less severe disease than previously thought, with alcohol consumption significantly impacting its prognosis. Promoting alcohol abstinence in hepatitis C patients can reduce illness, deaths, and healthcare expenses.

Area of Science:

Hepatology
Infectious Diseases
Public Health

Background:

Hepatitis C (HCV) was historically considered a severe liver disease.
Emerging evidence suggests a variable disease course, potentially less severe than initially understood.
Alcohol consumption is a critical factor influencing hepatitis C outcomes.

Purpose of the Study:

To evaluate the impact of alcohol consumption on hepatitis C prognosis.
To assess the potential benefits of alcohol abstinence in managing hepatitis C.
To analyze the implications for morbidity, mortality, and healthcare costs.

Main Methods:

Review of existing epidemiological data on hepatitis C.
Analysis of studies correlating alcohol intake with hepatitis C progression.

More Related Videos

Lipid Droplet Isolation for Quantitative Mass Spectrometry Analysis

Lipid Droplet Isolation for Quantitative Mass Spectrometry Analysis

Published on: April 17, 2017

The CYP2D6 Animal Model: How to Induce Autoimmune Hepatitis in Mice

The CYP2D6 Animal Model: How to Induce Autoimmune Hepatitis in Mice

Published on: February 3, 2012

Related Experiment Videos

Last Updated: Jul 14, 2026

A Protocol for Analyzing Hepatitis C Virus Replication

A Protocol for Analyzing Hepatitis C Virus Replication

Published on: June 26, 2014

Lipid Droplet Isolation for Quantitative Mass Spectrometry Analysis

Lipid Droplet Isolation for Quantitative Mass Spectrometry Analysis

Published on: April 17, 2017

The CYP2D6 Animal Model: How to Induce Autoimmune Hepatitis in Mice

The CYP2D6 Animal Model: How to Induce Autoimmune Hepatitis in Mice

Published on: February 3, 2012

Cost-benefit analysis of alcohol abstinence interventions.

Main Results:

Alcohol consumption is a significant determinant of hepatitis C disease severity and progression.
Reduced morbidity and mortality are associated with alcohol abstinence in hepatitis C patients.
Promoting abstinence can lead to considerable reductions in treatment costs.

Conclusions:

Alcohol abstinence is a crucial modifiable factor for improving hepatitis C patient outcomes.
Public health initiatives encouraging alcohol cessation are vital for managing hepatitis C.
Interventions targeting alcohol consumption can mitigate the long-term burden of hepatitis C.